Galapagos NV:企業のM&A・事業提携・投資動向

◆英語タイトル:Galapagos NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2067
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:261
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Galapagos NV – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Galapagos NV since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Galapagos NV’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Galapagos NV. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Galapagos NV’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Galapagos NV and its subsidiaries since 2007.
- Information about key financial and legal advisors for Galapagos NV’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Galapagos NV’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Deal reports 7
PARTNERSHIP 17
Partnership – Overview 17
Partnership – Deal reports 18
CAPITAL RAISING 224
Capital Raising – Overview 224
Capital Raising – Deal reports 225
DIVESTMENTS 239
Divestments – Overview 239
Divestments – Deal reports 240
PRIVATE EQUITY & OWNERSHIP 246
Private Equity and Ownership – Deal reports 246
APPENDIX 251
Contact Us 251
About MarketLine Financial Deals Database 251
Deal Definition and Methodology 253
About MarketLine 260

List of Tables
Table 1: Galapagos NV partnership volume and value trend (2014-YTD2018)
Table 2: Galapagos NV partnership trend by key deal type (2014-YTD2018)
Table 3: Galapagos NV capital raising volume and value trend (2014-YTD2018)
Table 4: Galapagos NV capital raising by deal type (2014-YTD2018)
Table 5: Galapagos NV divestments volume and value trend (2014-YTD2018)
Table 6: Galapagos NV divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Galapagos NV partnership volume and value trend (2014-YTD2018)
Figure 2: Galapagos NV partnership trend by key deal type (2014-YTD2018)
Figure 3: Galapagos NV capital raising volume and value trend (2014-YTD2018)
Figure 4: Galapagos NV capital raising by deal type (2014-YTD2018)
Figure 5: Galapagos NV divestments volume and value trend (2014-YTD2018)
Figure 6: Galapagos NV divestments by geography (2014-YTD2018)

★海外企業調査レポート[Galapagos NV:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trent Ltd (TRENT):企業の財務・戦略的SWOT分析
    Trent Ltd (TRENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mtr Corporation Ltd:企業の戦略・SWOT・財務分析
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hilton Worldwide Holdings Inc:戦略・SWOT・企業財務分析
    Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Richoux Group Plc:企業の戦略・SWOT・財務情報
    Richoux Group Plc - Strategy, SWOT and Corporate Finance Report Summary Richoux Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Arcam AB:企業の戦略的SWOT分析
    Arcam AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Nutra Pharma Corp (NPHC):医療機器:M&Aディール及び事業提携情報
    Summary Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis …
  • Petroleos de Venezuela SA:企業の戦略的SWOT分析
    Petroleos de Venezuela SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • OMRON Corporation:企業の戦略・SWOT・財務分析
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Jim Pattison Group:企業の戦略・SWOT・財務情報
    The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report Summary The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Celgene Corp (CELG):製薬・医療:M&Aディール及び事業提携情報
    Summary Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation. Its product portfolio includes Vidaz …
  • Salesforce.Com Inc (CRM):企業の財務・戦略的SWOT分析
    Salesforce.Com Inc (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mckesson Europe AG.:企業の戦略・SWOT・財務情報
    Mckesson Europe AG. - Strategy, SWOT and Corporate Finance Report Summary Mckesson Europe AG. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ceska Sprava Socialniho Zabezpeceni:企業の戦略的SWOT分析
    Ceska Sprava Socialniho Zabezpeceni - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Elavon, Inc.:企業の戦略・SWOT・財務情報
    Elavon, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elavon, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • KEPCO Plant Service & Engineering Co Ltd (051600):企業の財務・戦略的SWOT分析
    KEPCO Plant Service & Engineering Co Ltd (051600) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • Sumitomo Heavy Industries Ltd (6302):企業の財務・戦略的SWOT分析
    Sumitomo Heavy Industries Ltd (6302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fubon Bank (Hong Kong) Ltd:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Landis+Gyr AG (LAND):電力:M&Aディール及び事業提携情報
    Summary Landis+Gyr AG (Landis+Gyr) is an integrated energy management company that provide end-to-end advanced metering solutions. It delivers comprehensive services including cloud services, managed services, smart grid services, software services, solutions consulting and support services. The com …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆